Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor-Reference-Cited by-同舟云学术

Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor

Published:1991-01 Issue:1 Volume:102 Page:251-259
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Merritt Janet E.,Hallam Trevor J.,Brown Anthony M.,Boyfield Isobel,Cooper David G.,Hickey Deirdre M.B.,Jaxa-Chamiec Albert A.,Kaumann Alberto J.,Keen Mary,Kelly Eamonn,Kozlowski Ursula,Lynham James A.,Moores Kitty E.,Murray Kenneth J.,MacDermot John,Rink Timothy J.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1991.tb12162.x/fullpdf

Reference40 articles.

1. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors;ARMSTRONG;Br. J. Pharmacol.,1989

2. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities;ASHBY;Mol. Pharmacol.,1989

3. Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: prostanoid structure-activity relationships;BLAIR;Br. J. Pharmacol.,1980

4. The binding of [3H]-prostacyclin to membranes of a neuronal somatic cell hybrid;BLAIR;Br. J. Pharmacol.,1981

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding;BRADFORD;Anal Biochem.,1976

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An octimibate derivative, Oxa17, enhances cholesterol efflux and exerts anti-inflammatory and atheroprotective effects in experimental atherosclerosis;Biochemical Pharmacology;2021-06

2. Beyond Bioisosterism: New Concepts in Drug Discovery;Comprehensive Medicinal Chemistry III;2017

3. Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male Subjects;Clinical Therapeutics;2016-05

4. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins;Prostaglandins & Other Lipid Mediators;2013-10

5. International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress;Pharmacological Reviews;2011-07-13